Does improved access and greater choice of nicotine replacement therapy affect smoking cessation success? Findings from a randomised controlled trial

Show simple item record Greenaway, Natalie en Howe, C en Bullen, C en Grigg, M en Glover, M en McRobbie, H en Laugesen, M en Jiang, J en Chen, M-H en Whittaker, R en Rodgers, A en 2012-06-12T00:50:07Z en 2011-06 en
dc.identifier.citation Addiction 106(6):1176-1185 2011 en
dc.identifier.issn 0965-2140 en
dc.identifier.uri en
dc.description.abstract To determine the effect of offering smokers who want to quit easy access to nicotine replacement therapy (NRT), a period of familiarization and choice of product on smoking abstinence at 6 months. Design Single-blind, randomized controlled trial. Setting New Zealand. Participants A total of 1410 adult smokers who called the national Quitline for quitting support were randomized to usual Quitline care or a box containing different NRT products (patch, gum, inhaler, sublingual tablet, oral pouch) to try for a week prior to quitting, and then to choose one or two of these products for 8 weeks’ use. Measurements The primary outcome was 7-day point prevalence smoking abstinence 6 months after quit day. Secondary outcomes included continuous abstinence, cigarette consumption, withdrawal, NRT choice and serious adverse events at 1 and 3 weeks and 3 and 6 months. Findings No differences in 6-month quit rates (7-day point prevalence or continuous abstinence) were observed between the groups. However, smokers allocated to the intervention group were more likely to have quit smoking at 3 months [self-reported point prevalence, relative risk (RR) = 1.17, 95% confidence interval (CI): 1.02, 1.35, P = 0.03], had a longer time to relapse (median 70 days versus 28 days, P < 0.01) and used significantly more NRT. The selection box concept was highly acceptable to users, with the patch and inhaler combination the most popular choice (34%). Conclusions In terms of smoking abstinence at 6 months, offering smokers who want to quit free access to a wide range of nicotine replacement therapy, including a 1-week period of familiarization and choice of up to two products, appears no different to offering reduced cost and choice of nicotine replacement therapy, with no familiarization period. en
dc.publisher Auckland UniServices Limited en
dc.relation.ispartofseries Addiction en
dc.rights Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. en
dc.rights.uri en
dc.title Does improved access and greater choice of nicotine replacement therapy affect smoking cessation success? Findings from a randomised controlled trial en
dc.type Journal Article en
dc.identifier.doi 10.1111/j.1360-0443.2011.03419.x en
pubs.issue 6 en
pubs.begin-page 1176 en
pubs.volume 106 en
dc.rights.holder Copyright: Auckland UniServices Limited en en
pubs.end-page 1185 en
dc.rights.accessrights en
pubs.subtype Article en
pubs.elements-id 249666 en Medical and Health Sciences en Population Health en Pacific Health en
dc.identifier.eissn 1360-0443 en
pubs.record-created-at-source-date 2011-12-02 en

Files in this item

Find Full text

This item appears in the following Collection(s)

Show simple item record


Search ResearchSpace